Inventor · Rezé, FR

Bernard Vanhove

22Patents
3h-index
19Co-inventors
60Inventor score

Filing activity: Dec 26, 2001 → Sep 9, 2022

Most-cited inventions

PatentTitleAreaCited byStatus
US9244059B2 Cytotoxic anti-LAG-3 monoclonal antibody and its use in the treatment or prevention of organ transplant rejection and autoimmune disease Physics 29 Active
US7723482B2 Anti-CD28 antibody Chemistry; Metallurgy 17 Expired
US9447182B2 Antibodies directed against the alpha chain of IL7 receptor—their use for the preparation of drug candidates Chemistry; Metallurgy 4 Active
US10364287B2 Anti-CD28 humanized antibodies Chemistry; Metallurgy 3 Active
US8785604B2 Anti-CD28 humanized antibodies Chemistry; Metallurgy 3 Active
US10428152B2 Antibodies directed against CD127 Physics 2 Active
US9562098B2 Anti-CD28 humanized antibodies Chemistry; Metallurgy 2 Active
US11279766B2 Anti-SIRPa antibodies and their therapeutic applications Physics 2 Active
US11440964B2 Method for treating a pathological condition involving the activation or proliferation of CD127 positive cells with an anti-CD127 antibody Physics 1 Active
US9587023B2 Recombinant monovalent antibodies Emerging Cross-Sectional Technologies 1 Active
US12258577B2 Method effector cells using anti-CD127 antibodies for applications in cell therapy Chemistry; Metallurgy 0 Active
US12091464B2 Method of promoting a t-cell response or treating cancer by administering an antagonist to human c-type lectin-like receptor-1 (CLEC-1) Chemistry; Metallurgy 0 Active
US8785138B2 Monovalent ligands of the human CD28 receptor Chemistry; Metallurgy 0 Active
US11098128B2 Antibodies and polypeptides directed against CD127 Chemistry; Metallurgy 0 Active
US11926671B2 Antibodies and polypeptides directed against CD127 Chemistry; Metallurgy 0 Active
US12371502B2 Antibodies directed against CD127 Physics 0 Active
US11365257B2 Methods for promoting t cells response by administering an antagonist of human c-type lectin-like receptor 1 (CLEC-1) Chemistry; Metallurgy 0 Active
US11884723B2 Use of anti-human SIRPa v1 antibodies and method for producing anti-SIRPa v1 antibodies Emerging Cross-Sectional Technologies 0 Active
US11713356B2 Modified bifunctional anti-human signal regulatory protein alpha (SIRPa) antibody and method of use thereof for treating cancer Chemistry; Metallurgy 0 Active
US10689444B2 Recombinant monovalent antibodies Emerging Cross-Sectional Technologies 0 Active
US12252546B2 Anti-SIRPa antibodies and their therapeutic applications Physics 0 Active
US12331115B2 Uses of anti-SIRPg antibodies Physics 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.